Boston Scientific rises as FDA clears new urology fluid management system

Boston Scientific

30/03/2026 12:29

** Shares of medical device maker Boston Scientific BSX.N rise 2.1% to $69.51 premarket

** Gets FDA clearance for its Asurys Fluid Management System for common urology procedures

** Device automatically adjusts fluid flow using real-time pressure data during surgeries such as kidney stone removal and prostate treatment, lowering infection risk or kidney damage

** Eyes limited U.S. market release in the coming days

** Shares rose ~7% in 2025

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))